about wellinks

Mission and Vision Statement

At Wellinks, we are the COPD disease management company committed to empowering people to live fully and breathe freely by improving outcomes for those we serve. We see a future where COPD care is designed and delivered around the individual and supported by a team striving to help them live a healthier, more fulfilling life.

1

We are principled.
Always ethical and trustworthy. We say what we do, and we do what we say.

2

We are effective.
We are results-oriented.  We measure what matters and are outcomes driven.

3

We are authentic.
We are human. We celebrate diversity, inclusion and seek the perspective of others.

4

We are collaborative.
We are team players. We work together, empower people, and celebrate relationships.

5

We are innovative.
We take courageous action in our pursuit to improve lives.

People

Executive team
Alex Waldron - Chief Executive Officer (CEO)

Alex Waldron

Chief Executive Officer

Geoff Matous - President

Geoff Matous

President and Chief Commercial Officer

Ellen Su - Chief Product Officer

Ellen Su

Chief Product Officer

Ryan McMillian - Chief Financial Officer

Ryan McMillian

Chief Financial Officer

Abi Sundaramoorthy MD

Chief Medical Officer

board of directors
Kevin Rakin - Chair of the Board

Kevin Rakin

Chair of the Board

Henry Weinstein - Director

Henry Weinstein

Director

Steven Bruso

Director

Alex Waldron - Chief Executive Officer (CEO)

Alex Waldron

Chief Executive Officer

Wellinks has 5 years of experience building towards full-stack COPD Management.

2017
FDA Clearance and Launch of Flyp Nebulizer
Manufacturing at scale. CVS Health HUBs
2018
2019
$1M Device Revenue>20.000 COPD Customers
1st Integrated Virutal COPD Solutions
2020
2021
1st Clinical Study Complete & First IDN Partnership
Full Stack COPD Management
2022
Flyp Logo